This suggests that GH secretagogues may have a role in short stature in subjects with GH deficiency, as well as potentially regulating body composition in older subjects
doi: 10.1155/2020/1484321 165 SaadMAEltarzyMAAbdel SalamRMAhmedMAE
Changes coming to weight loss drug coverage benefits, effective January 1, 2025 Effective January 1, 2025, Independence Blue Cross (IBX) will no longer offer coverage for drugs including glucagon-like peptide-1 receptor antagonist (GLP-1) and non-glucagon-like peptide-1 receptor antagonist (non-GLP-1) indicated for and prescribed solely for weight loss in the absence of other FDA-approved clinical indications
These injections treat hormone deficiencies, promote muscle growth, aid in recovery, regulate metabolism, enhance immune response, and improve skin condition
Patients often eat 30 to 50 percent fewer calories than before treatment